Gene Synthesis Market Research Report 2021-2028: Analysis by Service (Antibody, Viral), Application (Gene & Cell Therapy Development, Disease Diagnosis) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Gene Synthesis Market Size, Share & Trends Analysis Report 2021-2028" has been added to ResearchAndMarkets.com's offering.

The global gene synthesis market size is expected to reach USD 5.58 billion by 2028, growing at a CAGR of 18.1%

Gene synthesis space is offering enormous potential for new biological functionality. This has resulted in the introduction of supportive government policies associated with synthetic biology, thereby driving the market.

Industry participants strive for developing proprietary and new technologies to strengthen their market presence. Furthermore, the establishment of organizations and forums helps encourage researchers to opt and study genetic engineering-related concepts and develop innovative technologies, which is also a notable growth driver of this space.

Considering this space as a lucrative source of revenue, companies are focusing on collaborations with various universities for on-site training, online workshops, and sponsored projects to boost their expertise portfolio. This is also expected to generate interest among research professionals by helping them realize the potential of this field and therefore spurring adoption in the market.

North America, with the U.S. at the forefront, emerged as the highest revenue-generating region in 2020 due to the presence of a substantial number of key players and a well-established molecular biology landscape. Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 on account of the presence of large clinical subjects and low operational costs.

Key players are undertaking various strategic initiatives, such as mergers & acquisitions and new product development, to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta's offerings in AI-enabled multi-omic data analysis services and applications.

Gene Synthesis Market Report Highlights

• Being a conventional well-established method, solid-phase synthesis dominated the global market in 2020. This method offers high accuracy, which contributes to its dominance
• The PCR-based synthesis method is anticipated to witness the fastest CAGR from 2021 to 2028 owing to low cost, higher yield, and ability to synthesize large gene fragments
• Antibody DNA synthesis captured the maximum revenue share in the 2020 market owing to the presence of a substantial number of companies offering these services for this segment
• The academic and government research institutes segment led the global market in 2020 as the majority of the gene synthesis process is carried out in the research settings for investigational and clinical research programs
• Gene & cell therapy development accounted for the largest revenue share in 2020 owing to the rising number of R&D programs for the development of cell and gene therapies
• Disease diagnosis is anticipated to register the fastest CAGR during the forecast period owing to the rising investments for the development of high throughput disease diagnosis modalities

Market Dynamics

Market driver analysis

• Rising investment in the synthetic biology market
• Advent of enzymatic DNA synthesis process
• Technological advancements in the DNA synthesis platforms
• Declining price of DNA synthesis & sequencing

Market restraint analysis

• Lack of skilled professionals
• Misuse of gene synthesis
• Market opportunity Analysis
• Rising popularity of targeted therapy

Market challenge Analysis

• Technical & ethical challenges related to genetic modification

COVID-19 Impact Analysis: Gene Synthesis Market

Gene Synthesis Market: Market Analysis Tools

• Industry Analysis - Porter's
• SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)

Regulatory framework

Penetration and Growth Prospect Mapping for Method, 2020

Companies Mentioned

• GenScript
• Brooks Automation, Inc.
• Proteogenix
• Origene Technologies, Inc.
• Integrated DNA Technologies, Inc.
• ProMab Biotechnologies, Inc.
• biomatix
• Thermo fisher scientific inc.
• Twist Bioscience
• Boster biological technology

For more information about this report visit https://www.researchandmarkets.com/r/pf1nqi